↓ Skip to main content

CSF β-amyloid is not a prognostic marker in multiple sclerosis patients

Overview of attention for article published in Multiple Sclerosis and Related Disorders, August 2022

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

news
1 news outlet

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
CSF β-amyloid is not a prognostic marker in multiple sclerosis patients
Published in
Multiple Sclerosis and Related Disorders, August 2022
DOI 10.1016/j.msard.2022.104096
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 2 15%
Librarian 1 8%
Other 1 8%
Student > Bachelor 1 8%
Student > Master 1 8%
Other 0 0%
Unknown 7 54%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 3 23%
Business, Management and Accounting 1 8%
Agricultural and Biological Sciences 1 8%
Neuroscience 1 8%
Unknown 7 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 September 2022.
All research outputs
#4,841,279
of 25,394,764 outputs
Outputs from Multiple Sclerosis and Related Disorders
#894
of 3,096 outputs
Outputs of similar age
#97,268
of 431,621 outputs
Outputs of similar age from Multiple Sclerosis and Related Disorders
#37
of 148 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,096 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,621 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 148 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.